Skip to main content

Animations

MJFF Publications

2641 - 2650 of 8571 Results
Title
Year
  • Year
  • 2019
  • 2011
  • 2023
  • 2017
  • 2020
  • 2021
  • 2007
  • 2020
  • 2018
  • 2017
  • Summary Details
    RESTRICTED
    Title: Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.025
    Best OA location URL:
    Citation Count: 67
  • Summary Details
    RESTRICTED
    Title: Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s00702-011-0682-x
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: Digital technologies: Innovations that transform the face of drug development
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.13533
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00440
    Best OA location URL:
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: Unmet needs in Parkinson disease: Motor and non-motor
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.024
    Citation Count: 60
  • Summary Details
    RESTRICTED
    Title: Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology.
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.17879/freeneuropathology-2021-3326
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: γ‐Synuclein and the progression of cancer
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.07-8379rev
    Best OA location URL:
    Citation Count: 91
  • Summary Details
    RESTRICTED
    Title: Clinical and Imaging Markers of Prodromal Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00395
    Citation Count: 91
  • Summary Details
    RESTRICTED
    Title: Biomarkers for cognitive dysfunction in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.023
    Best OA location URL:
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003
    Best OA location URL:
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.